Patent holdings for IPC class C07J 71/00

Total number of patents in this class: 509

10-year publication summary

44
27
48
41
32
38
35
27
22
14
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Regeneron Pharmaceuticals, Inc.
4647
20
Nzp UK Limited
31
17
Eli Lilly and Company
4044
16
Sage Therapeutics, Inc.
332
16
Reata Pharmaceuticals, Inc.
116
14
Chiesi Farmaceutici S.p.A.
964
11
Beijing Peking University WBL Biotech Co. Ltd
31
9
Neupharma, Inc.
72
9
InterCept Pharmaceuticals, Inc.
195
8
AstraZeneca AB
2830
7
Socpra Sciences et Genie S.E.C.
209
7
GENETIC s.p.a.
13
7
Forendo Pharma Ltd.
18
6
Nicox Ophthalmics, Inc.
21
6
Scynexis, Inc.
65
6
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
862
6
Daiichi Sankyo Company, Limited
1892
5
Oncology Research International Limited
8
5
Duality Biologics (Suzhou) Co., Ltd.
52
5
Kimberly-clark Worldwide, Inc.
5297
4
Other owners 325